These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 2838332)

  • 1. A highly selective ligand for brain delta opiate receptors, a cyclopropyl(E)Phe(4)-enkephalin analog, suppresses mu receptor-mediated thermal analgesia by morphine.
    Shimohigashi Y; Takano Y; Kamiya H; Costa T; Herz A; Stammer CH
    FEBS Lett; 1988 Jun; 233(2):289-93. PubMed ID: 2838332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study.
    Bodnar RJ; Williams CL; Lee SJ; Pasternak GW
    Brain Res; 1988 Apr; 447(1):25-34. PubMed ID: 2838129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-Ala2,Leu5,Cys6]enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors.
    Calcagnetti DJ; Fanselow MS; Helmstetter FJ; Bowen WD
    Peptides; 1989; 10(2):319-26. PubMed ID: 2547203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS; Mosberg HI; Porreca F
    NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).
    Ukai M; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(1):32-7. PubMed ID: 2894701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between rat brain and mouse vas deferens delta opioid receptors.
    Vaughn LK; Wire WS; Davis P; Shimohigashi Y; Toth G; Knapp RJ; Hruby VJ; Burks TF; Yamamura HI
    Eur J Pharmacol; 1990 Feb; 177(1-2):99-101. PubMed ID: 2160370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two penicillamine-containing enkephalins: mu, not delta, activity produces analgesia.
    Leander JD; Gesellchen PD; Mendelsohn LG
    Neuropeptides; 1986; 8(2):119-25. PubMed ID: 3020472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats.
    Satoh M; Kubota A; Iwama T; Wada T; Yasui M; Fujibayashi K; Takagi H
    Life Sci; 1983; 33 Suppl 1():689-92. PubMed ID: 6141508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional interactions of opioid peptides at mu and delta sites in rat brain.
    Hewlett WA; Barchas JD
    Peptides; 1983; 4(6):853-8. PubMed ID: 6324140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy.
    Delay-Goyet P; Ruiz-Gayo M; Baamonde A; Gacel G; Morgat JL; Roques BP
    Pharmacol Biochem Behav; 1991 Jan; 38(1):155-62. PubMed ID: 1850135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.